Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Guardian Bio
AddedMar 22, 2024
UpdatedJul 3, 2026
Guardian Bio

Guardian Bio

Seed

Guardian Bio: Personalized dendritic cell therapy to boost immune fight against cancer.

HQ
Boston, MA, US
Founded
2022
Accelerator
Y Combinator logoY CombinatorS22
Overview
Compare
Fundraising
Employees
Website

Guardian Bio was founded by Ananya Zutshi, MS, MBA, and Karolina Palucka, MD, PhD, with a mission to revolutionize cancer treatment through dendritic cell-based therapies. The company focuses on leveraging the body's immune system to combat cancer, specifically targeting the dysfunction of dendritic cells in cancer patients. Guardian Bio aims to restore anti-cancer immunity in late-stage solid tumor patients by developing personalized dendritic cell therapies that enhance anti-tumor activity.

Notable figures affiliated with Guardian Bio include co-founders Ananya Zutshi and Karolina Palucka, both of whom bring extensive expertise in science and medicine. The company has garnered attention for its innovative approach to immunotherapy and regenerative medicine. Guardian Bio's impact lies in its potential to offer new hope for late-stage cancer patients by addressing a critical bottleneck in current cancer treatments, thereby advancing the field of oncology.

Guardian Bio - Similar Companies

GentiBio logo

GentiBio

gentibio.com

Fresh Wind Biotechnologies USA logo

Fresh Wind Biotechnologies USA

A2 Biotherapeutics logo

A2 Biotherapeutics

a2bio.com

Serinus Biosciences logo

Serinus Biosciences

serinus.bio

Geneius logo

Geneius

geneius.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

Asher Bio logo

Asher Bio

asherbio.com

Immpact Bio logo

Immpact Bio

immpact-bio.com

Granza Bio logo

Granza Bio

granzabio.com

2seventy bio logo

2seventy bio

2seventybio.com

ImmuCision Biotherapeutics logo

ImmuCision Biotherapeutics

Eugit Therapeutics logo

Eugit Therapeutics

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Avenge Bio logo

Avenge Bio

avengebio.com

Larkspur Biosciences logo

Larkspur Biosciences

larkspur.bio

Guardian Bio - Quick Facts

Who are Guardian Bio's competitors?

Companies similar to Guardian Bio include GentiBio, Fresh Wind Biotechnologies USA, A2 Biotherapeutics and Serinus Biosciences.

When was Guardian Bio founded?

Guardian Bio was founded in 2022.

Where is Guardian Bio's headquarters located?

Guardian Bio's headquarters is located in Boston, MA, US.

When was Guardian Bio's last funding round?

Guardian Bio's most recent funding round was for $500k (USD) in August 2022.

How much has Guardian Bio raised to-date?

As of Aug 22, 2022, Guardian Bio has raised a total of $500k (USD).

How many employees does Guardian Bio have?

Guardian Bio has 3 employees as of Feb 24, 2024.

Guardian Bio - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Cancer Therapy
Tags
  • Consulting
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified